1. Home
  2. OXBR vs ADVB Comparison

OXBR vs ADVB Comparison

Compare OXBR & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oxbridge Re Holdings Limited

OXBR

Oxbridge Re Holdings Limited

HOLD

Current Price

$1.59

Market Cap

8.1M

Sector

Finance

ML Signal

HOLD

ADVB

Advanced Biomed Inc.

HOLD

Current Price

$5.09

Market Cap

7.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OXBR
ADVB
Founded
2013
2014
Country
Cayman Islands
United States
Employees
4
31
Industry
Property-Casualty Insurers
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.1M
7.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OXBR
ADVB
Price
$1.59
$5.09
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
58.8K
10.1K
Earning Date
05-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$80.09
N/A
Revenue Next Year
$85.22
N/A
P/E Ratio
N/A
$1.26
Revenue Growth
N/A
N/A
52 Week Low
$0.66
$0.19
52 Week High
$2.85
$7.70

Technical Indicators

Market Signals
Indicator
OXBR
ADVB
Relative Strength Index (RSI) 70.47 56.44
Support Level $1.51 $3.81
Resistance Level $2.09 $5.66
Average True Range (ATR) 0.17 0.49
MACD 0.03 0.02
Stochastic Oscillator 72.04 60.90

Price Performance

Historical Comparison
OXBR
ADVB

About OXBR Oxbridge Re Holdings Limited

Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer that provides reinsurance solutions through its subsidiary. The company focuses on underwriting fully collateralized reinsurance contracts for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. It specializes in underwriting medium-frequency, high-severity risks where insufficient data exists to effectively analyze the risk/return profile of reinsurance contracts. The company generates revenue from three principal sources: premiums assumed from reinsurance on property and casualty business; income from investments, including unrealized gains or losses on other investments; and income from SurancePlus management fees.

About ADVB Advanced Biomed Inc.

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

Share on Social Networks: